Pulmonary pharmacology and therapeutics

Pulmonary pharmacology and therapeutics

Impact of socioeconomic status on participation and outcomes in the Salford Lung Studies
Rupert Jones, Andy Nicholls, Dominy Browning, Nawar Diar Bakerly, Ashley Woodcock, Jørgen Vestbo, David A. Leather, Loretta Jacques, James Lay-Flurrie, Henrik Svedsater, Susan Collier

ERJ Open Research Jan 2020, 6 (1) 00193-2019; DOI: 10.1183/23120541.00193-2019
Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study
Katerina Antoniou, Katerina Markopoulou, Argyrios Tzouvelekis, Athina Trachalaki, Eirini Vasarmidi, Jiannis Organtzis, Vasilios Tzilas, Evangelos Bouros, Georgia Kounti, Christina Rampiadou, Serafeim-Chrysovalantis Kotoulas, Fotini Bardaka, Eleni Bibaki, Evangelia Fouka, Georgios Meletis, Stavros Tryfon, Zoe Daniil, Despina Papakosta, Demosthenes Bouros

ERJ Open Research Jan 2020, 6 (1) 00172-2019; DOI: 10.1183/23120541.00172-2019
Dupilumab improves lung function in patients with uncontrolled, moderate-to-severe asthma
Mario Castro, Klaus F. Rabe, Jonathan Corren, Ian D. Pavord, Constance H. Katelaris, Yuji Tohda, Bingzhi Zhang, Megan S. Rice, Jaman Maroni, Paul Rowe, Gianluca Pirozzi, Nikhil Amin, Marcella Ruddy, Bolanle Akinlade, Neil M.H. Graham, Ariel Teper

ERJ Open Research Jan 2020, 6 (1) 00204-2019; DOI: 10.1183/23120541.00204-2019
Oral corticosteroid-sparing effects of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis
Brian D. Kent, Grainne d'Ancona, Mariana Fernandes, Linda Green, Cris Roxas, Louise Thomson, Alexandra M. Nanzer, Joanne Kavanagh, Sangita Agarwal, David J. Jackson

ERJ Open Research Jan 2020, 6 (1) 00311-2019; DOI: 10.1183/23120541.00311-2019
Effect of long-acting β-agonists/glucocorticoids on human airway epithelial cell cytokine, transcriptomic and oxidative stress responses to cannabis smoke
Ryan D. Huff, Jennifer A. Aguiar, Wayne Tse, Martin R. Stämpfli, Brendan J. McConkey, Andrew C. Doxey, Jeremy A. Hirota

ERJ Open Research Jan 2020, 6 (1) 00265-2019; DOI: 10.1183/23120541.00265-2019
Efficacy of azithromycin in severe asthma from the AMAZES randomised trial
Peter G. Gibson, Ian A. Yang, John W. Upham, Paul N. Reynolds, Sandra Hodge, Alan L. James, Christine Jenkins, Matthew J. Peters, Guy B. Marks, Melissa Baraket, Heather Powell, Jodie L. Simpson

ERJ Open Research Oct 2019, 5 (4) 00056-2019; DOI: 10.1183/23120541.00056-2019
Isolating peripheral effects of endogenous opioids in modulating exertional breathlessness in people with moderate or severe COPD: a randomised controlled trial
David C. Currow, Toby Hunt, Sandra Louw, Danny Eckert, Peter Allcroft, Tim H.M. To, Aine Greene, Malgorzata Krajnik, Don Mahler, Magnus Ekström

ERJ Open Research Oct 2019, 5 (4) 00153-2019; DOI: 10.1183/23120541.00153-2019
Efficacy of two dosing schemes of a liquid containing ivy leaves dry extract EA 575 versus placebo in the treatment of acute bronchitis in adults
Axel Schaefer, Fanny Ludwig, Bruno M. Giannetti, Michael Bulitta, Anja Wacker

ERJ Open Research Oct 2019, 5 (4) 00019-2019; DOI: 10.1183/23120541.00019-2019
Real-life effectiveness of omalizumab in difficult-to-treat versus severe asthma: a national cohort study in Belgium
Katia M.C. Verhamme, Catherine Lucet, Alain Van Meerhaeghe, Guy G.O. Brusselle, Marie-Laurence Lambert

ERJ Open Research Oct 2019, 5 (4) 00253-2018; DOI: 10.1183/23120541.00253-2018
Clinical effectiveness of once-daily fluticasone furoate/umeclidinium/vilanterol in usual practice: the COPD INTREPID study design
Sally Worsley, Neil Snowise, David M.G. Halpin, Dawn Midwinter, Afisi S. Ismaila, Elaine Irving, Leah Sansbury, Maggie Tabberer, David Leather, Chris Compton

ERJ Open Research Oct 2019, 5 (4) 00061-2019; DOI: 10.1183/23120541.00061-2019

Main menu

User menu

Search

Pulmonary pharmacology and therapeutics

Pages

Contact us